Search
for
Sort by
Research 451–480 of 1000+
- Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery
- Finasteride Induced Cerebral Venous Thrombosis
- High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
- Serenoa repens: A Phytochemical and Pharmacological Review
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- Editorial: Advances in reproductive biotechnologies in carnivores
- Structural basis for the catalysis and inhibition of human steroid 5α‐reductase 2
- Advances in Knowledge of Androgens: How Intentional and Accidental Neurosteroid Changes Inform Us of Their Action and Role
- 전립선 비대유도 쥐의 전립선 조직에서 울금 급여에 따른 염증인자의 변화
- Saw Palmetto
- 利用地面光達點雲建置三維房屋模型;Reconstructing 3D Building Model from Terrestrial LiDAR Point Cloud
- 1153 ERECTILE HEMODYNAMICS ASSESSMENT IN MEN WITH PERSISTENT ERECTILE DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE
- VIBRATIONAL SPECTROSCOPIC INVESTIGATION AND MOLECULAR STRUCTURE OF A 5α-REDUCTASE INHIBITOR: FINASTERIDE
- Acute urinary retention: risks and management.
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Contrast-Enhanced Ultrasound (CEUS) Evaluation of Canine Prostatic Hyperplasia before and after Osaterone Acetate Therapy: Preliminary Results
- Doxazosin and finasteride alone or in combination: the PREDICT study
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Editorial Comment
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Hiperplasia quística prostática en un perro joven: reporte de caso
- Glatze in jungen Jahren könnte Risikofaktor für BPH sein
- Intervention beim PCa: leichte Pluspunkte für radikale Prostatektomie
- UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood
- In vitro and In vivo Effects of 17β-N-(4-phenylcarbamoyl) androst-4-en-3- one Derivatives as 5a-reductase Inhibitors on Androgen-dependent Glands
- Structure of human type II 5 alpha-reductase gene.
- Pre-receptor regulation of the androgen receptor
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases